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For the last two decades, caspases, a family of cysteine-aspartic proteases, have
evolved from being considered solely as regulators of apoptosis or inflammation to
having a wider range of functions. In this mini review, we focus on the most recent
“non-apoptotic” roles of caspases in the CNS, particularly in neurons, astrocytes and
oligodendrocytes. Non-apoptotic caspase functions in microglia have already been
reviewed extensively elsewhere. Here we discuss the involvement of caspases in the
activation of the inflammasome, autophagy, and non-apoptotic forms of cell death
such as necroptosis and pyroptosis. Also, we review the involvement of caspases in
synapses and the processing of aggregates key to neurodegenerative diseases such as
Parkinson’s, Alzheimer’s and Huntington’s diseases. Likewise, we mention the recently
described involvement of caspases in mitochondrial biogenesis, which is a function
independent of the enzymatic activity. We conclude discussing the relevance that “new”
functions of caspases have in the CNS and the future of this field of research.
Keywords: caspase, neuron, astrocytes, oligodendrocytes, inflammasome, necroptosis, neurodegeneration,
pyroptosis
INTRODUCTION
Caspases are a family of proteins belonging to the cysteine aspartate proteases classically associated
with different forms of programmed cell death (Stennicke and Salvesen, 1999; Hyman and Yuan,
2012; Tummers and Green, 2017).
Since the discovery of CED-3 in Caenorhabditis elegans (Ellis and Horvitz, 1986) and the caspase-
1/Interleukin-1 converting enzyme (ICE) (Thornberry et al., 1992; Yuan et al., 1993), caspases
were grouped based on their function as “apoptotic” or “inflammatory.” This classification has
remained useful to some extent until recently, since new non-apoptotic or non-inflammatory roles
have surfaced for caspases (Shalini et al., 2015; Baena-Lopez et al., 2018; Hollville and Deshmukh,
2018). Besides, over the last decade, evidence has been gathered detailing non-apoptotic roles for
caspases in astrocytes, neurons, oligodendrocytes (ODCs) and microglia (Acarin et al., 2007; Li
et al., 2010; Burguillos et al., 2011; Wagner et al., 2011).
The aim of this mini-review is to provide an update on the various functions of caspases (from
those described over two decades ago, to recent functions described within the last 5 years) in the
CNS, focusing mainly on neurons, astrocytes and ODCs (see Table 1). We will only briefly discuss
microglia cells as we recently published an in-depth review on this topic (Shen et al., 2018).
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TABLE 1 | Non-apoptotic functions of caspases in different cell types.
Cell type Model and caspase involved References
Inflammasome Astrocytes Primary cortical astrocytes from mice with Aβ1−42 (caspase-1) Ebrahimi et al., 2018
Primary glial cultures from WT, Nlrc4−/−, Nlrp3−/− and Asc−/− mice with
LPC(caspase-1)
Freeman et al., 2017;
Human primary astrocytes with ATP (caspase-1) Minkiewicz et al., 2013
SOD1 mouse model/ALS patients (caspase-1) Johann et al., 2015
Intracerebral hemorrhage mouse model (caspase-1) Wang et al., 2017
Mouse primary astrocytes with methamphetamine (caspase-11) Du et al., 2017
Microglia EAE mouse model (caspase-8) Zhang et al., 2018
Neurons Primary cultures of human neurons under serum-deprived conditions (caspase-1) Kaushal et al., 2015
APPSwe/PS1dE9 transgenic mice (caspase-1) Tan et al., 2014
Dopaminergic neurons from PD patients (caspase-1) von Herrmann et al., 2018
ODCs Administration prenatal of dexamethasone to mice (caspase-1) Maturana et al., 2017
Pyroptosis Astrocytes Ischemia induced by the oxygen-glucose deprivation in primary cultured astrocytes
from rats (caspase-1)
Xia et al., 2018
Stroke model in rats (caspase-1)
Cultured rat cortical astrocytes with bilirubin (caspase-1) Feng et al., 2018
Sepsis model in mice and rats induced by LPS (caspase-1) Li et al., 2019; Sun et al., 2019
Neurons Neurons Primary cultures of human neurons under serum-deprived conditions (caspase-1) Kaushal et al., 2015
Cultured cortical neurons from rats with Aβ (caspase-1) Tan et al., 2014
SCI model in rats (caspase-1, caspase-11) Lin et al., 2016; de Rivero
Vaccari et al., 2008
Caspase-1-/- mice subjected to controlled cortical impact injury (caspase-1) Liu et al., 2018
Ischemic stroke model in mice (caspase-1, caspase-11) Fann et al., 2018
Ocular hypertension-injured retina in mice (caspase-1) Pronin et al., 2019
ODCs EAE mouse model (caspase-1) McKenzie et al., 2018
MS patients (caspase-1)
Necroptosis ODCs EAE and Cuprizone mouse models of MS and in MS patients (caspase-8) Ofengeim et al., 2015
Osmotic demyelination syndrome model in mice (caspase-8) Bouchat et al., 2018
Neonatal rats subjected to hypoxia-ischemia (caspase-8) Qu et al., 2017
Neurons Global cerebral ischemia/reperfusion in CA1 neurons in rats (caspase-8) Xu et al., 2016
Subarachnoid hemorrhage induced brain injury model in rats (caspase-8) Chen et al., 2018;
Yuan et al., 2019
Models of retinal degeneration in rats (caspase-8) Jang et al., 2019
Astrocytes Mouse spinal cord astrocytes with LPS or TNF-α with zVAD (caspase-8) Fan et al., 2016
SCI model in mice (caspase-8)
Microglia Mice stereotaxically injected with LPC (caspase-8) Lloyd et al., 2019
Synapses Neurons Cultured neurons subjected to neurotrophic factor deprivation (caspase-3,
caspase-6, caspase-9)
Simon et al., 2012
Caspase-3 knockout mice (caspase-3) Ertürk et al., 2014
J20 APP transgenic mice (caspase-2) Pozueta et al., 2013
Caspase-9−/− mice (caspase-9) Ohsawa et al., 2010
Caspase-3−/−neonatal mice (caspase-3) Gu et al., 2017
Caspase-3 knockout mice and rats (caspase-3) Li et al., 2010
Tg2576-APPSwe mice (caspase-3) D’Amelio et al., 2011
Autophagy Neurons Primary cortical neurons from wt and casp2−/− mice with rotenone (caspase-2) Tiwari et al., 2011
PC12 cells and cortical neurons from rats with Aβ1−42 (caspase-3) Wang et al., 2017
APPSwe/PS1dE9 transgenic mice (caspase-3)
Mitochondria
Biogenesis
Neurons Dopaminergic cell line (procaspase-3) Kim et al., 2018
Caspases Inflammasome and Pyroptosis
The inflammasome (Martinon et al., 2002) is a multiprotein
intracellular complex that senses pathogenic microorganisms and
sterile stressors, which ultimately processes and releases IL-1β
and IL-18. The activation of the inflammasome consists of
a two-step pathway (First step: TLR activation; Second step:
e.g., ATP). This leads to caspase-1, caspase-11 (de Rivero
Vaccari et al., 2014; Walsh et al., 2014; Broz and Dixit, 2016;
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Voet et al., 2019) and caspase-8 (Zhang et al., 2018) activation.
Also intracellular lipopolysaccharide (LPS) may bind directly
to caspase-11, promoting its activation (Shen et al., 2018).
Inflammasomes are categorized as canonical (caspase-1) or non-
canonical (caspase-11) (Broz and Dixit, 2016) (for the general
signaling pathway, see Figure 1A). In microglia cells, a recent
study described a non-canonical inflammasome associated to
caspase-8 (and independently of caspase-1), in which microglia
were able to generate IL-1β in an Experimental autoimmune
encephalomyelitis (EAE) mouse model (Zhang et al., 2018).
This finding is contradictory of a previous study done in
Bone Marrow Derived Macrophages (BMDM), where caspase-
1 deficiency is necessary for caspase-8 processing and release of
IL-1β (Schneider et al., 2017).
The activation of the inflammasome can evolve into a process
of regulated cell death termed pyroptosis, which acts as a
defense mechanism against infection by inducing pathological
inflammation (Tait et al., 2014). In pyroptosis, both caspase-1
and caspase-11 (caspase-4 and caspase-5 in humans) have been
described as mediators of this type of cell death (for the general
signaling pathway, see Figure 1A; Aglietti et al., 2016; Pronin
et al., 2019).
Inflammasomes were originally described in immune cells
(Shen et al., 2018) though the presence of the inflammasome
in other cells than microglia in the CNS has been reported
too. In astrocytes, crucial regulators of the immune responses
in the injured CNS, the presence of canonical and non-
canonical inflammasomes occurs upon treatment with different
stimuli in vitro (Minkiewicz et al., 2013; Du et al., 2017;
Freeman et al., 2017; Ebrahimi et al., 2018). In vivo, high
expression levels of nucleotide-binding oligomerization domain-
like receptor protein (NLRP) 3 related to the neuroinflammatory
response has been found in astrocytes of SOD1 mice and in
Amyotrophic lateral sclerosis (ALS) patients (Johann et al., 2015).
Also, different studies showed astrocytic pyroptosis in animal
models of sepsis induced by LPS (Li et al., 2019; Sun et al., 2019).
Besides microglia and astrocytes, the presence of different
types of inflammasomes have been reported in non-immune
related cells, such as neurons (Figure 1B and Table 1).
Over 10 years ago, the existence of NACHT leucine-rich-
repeat protein 1 (NALP1) neuronal inflammasome was reported
(Kummer et al., 2007). Since then, several studies have
demonstrated that activation of the inflammasome occurs
in neurons, followed normally by cell death induced by
pyroptosis. In the context of Alzheimer’s disease (AD), pyroptosis
occurs upon amyloid-β (Aβ) treatment in vitro, as well
as in vivo in the APPSwe/PS1dE9 mice. In both cases,
either knockdown of NLRP1 (another type of inflammasome)
or caspase-1 conferred neuroprotection (Tan et al., 2014).
Interestingly, in a recent study, NLRP3 inflammasome was
characterized in dopaminergic neurons from Parkinson’s disease
(PD) patients (von Herrmann et al., 2018). In this study the
authors identified, via exome sequencing, a single-nucleotide
polymorphisms (SNPs) for NLRP3 which results in a less
soluble form of NLRP3 protein than NLRP3 wild-type.
This less soluble form was associated with a significantly
reduced risk of developing PD, highlighting the relevance
of NLRP3 inflammasome in dopaminergic neurons in PD
(von Herrmann et al., 2018).
In a recent study by Tsuchiya et al. (2019), the authors
described how it was possible to alter the type of neuronal death
(from pyroptosis to apoptosis), based on the levels of expression
of Gasdermin D (GSDMD). GSDMD is a specific substrate for
caspase-1, -4, -5 and -11, whose N-terminal cleavage product
has a pore-forming activity that causes cell swelling and lysis
via pyroptosis. In this sense, cortical neurons may die through
apoptosis instead of pyroptosis after oxygen-glucose deprivation
(OGD) and nigericin stimulation due to low expression of
GSDMD (Tsuchiya et al., 2019).
Finally, in ODCs, the relevance of inflammasome
activation has not been as well documented, with only a
few reports published. For instance, prenatal administration
of dexamethasone to mice, a treatment that promotes
demyelination, induces NLRP3, caspase-1 and Apoptosis-
associated speck-like protein containing a CARD (ASC)
expression in ODCs, which the authors suggested could be
contributing to demyelination (Maturana et al., 2017). Also,
pyroptosis has been observed in myelin-forming ODCs in
the EAE mice and in patients with Multiple sclerosis (MS)
(McKenzie et al., 2018). In this case, inhibition of caspase-1,
using the inhibitor VX-756, reduced pyroptosis in ODCs
and microglia and promoted neuroprotection and improved
performance in different neurobehavioral tests. In this case is
hard to distinguish if VX-756 beneficial effect over behavior is
based on inhibition of inflammasome and/or pyroptosis or both.
Caspases and Necroptosis
Originally necroptosis was considered a passive death of cells
under pathological conditions, where the cellular contents are
released and cause an immune response. However, currently it is
considered a cell death pathway regulated through the interaction
of different molecules including receptor-interacting protein
kinase (RIPK)-1 and RIPK3, mixed lineage kinase domain-like
protein (MLKL), and caspase-8 (whose activity is inhibited for
instance by caspase-8 or pan-caspase inhibitors) (Figure 1A; Tait
et al., 2014; Ofengeim et al., 2015).
Necroptosis mediates ODC degeneration induced by TNF-
α, whose binding to TNFR1 triggers caspase-8 activation, and
the inhibition of RIPK1 protects against ODC cell death in two
animal models to study MS, and also in cell culture (Ofengeim
et al., 2015). In the same paper, the authors found in cortical
lesions of human MS samples defective caspase-8 activation and
activation of RIPK1, RIPK3, and MLKL. Also in a different
in vivo model of osmotic demyelination syndrome, ODC cell
death has been linked to necroptosis based on an increase of
phospho-MLKL immunoreactivity (Bouchat et al., 2018), but
further experiments are needed to confirm this result.
In the developing brain, a study showed that neonatal rats
subjected to hypoxia–ischemia (HI) and ODCs from neonatal
rats treated with OGD together with the pan-caspase activity
inhibitor zVAD die via necroptosis (Qu et al., 2017). Treatments
aimed to block the interaction of RIPK3 with MLKL or CaMKIIδ,
a new described substrate of RIPK3, managed to decrease
necroptosis under these conditions (Qu et al., 2017).
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FIGURE 1 | Non-apoptotic roles for caspases in inflammasome, pyroptosis and necroptosis in the CNS. (A) Left panel represents the general mechanisms to trigger
both canonical and non-canonical inflammasome activation and subsequent pyroptosis. Also, it is included the recently described caspase-8 dependent
non-canonical inflammasome activation in microglia (mglia) and BMDM. Canonical inflammasome commences upon a first signal (“priming stage,” 1) induced by
DAMPS or PAMPS that promote the expression of the components of the inflammasome. Three types of inflammasome have been described so far (NLRs, AIM2,
and Pyrin inflammasomes). A second signal (2) is needed for inflammasome assembly via the protein adaptor ASC and caspase-1, which becomes active through
cleavage. Cleaved caspase-1 (Casp-1cl) may either cleave pro-IL1β into IL1β that will be released, or process gasdermin D (GSDMD), the known effector of
pyroptosis. In the non-canonical inflammasome, cytosolic LPS, from intracellular Gram negative bacteria binds with high affinity to caspase-11, provoking
self-assembly and its activation. Active caspase-11 indirectly promotes the cleavage of the pro-IL1β by activating the NLRP3 inflammasome and caspase-1.
Moreover, caspase-11 is also capable to directly cleave GSDMD to promote pyroptosis. Caspase-8 gets activated via the inflammasome in two different ways
depending on the cell type. In microglia, the inflammasome gets activated via TLR-IRAKM axis, that promotes caspase-8 activation and IL-1β release. In BMDM, in
the absence of GSDMD or caspase-1 activity, the inflammasome becomes activated upon Nigericin treatment, also promoting caspase-8 activation and inducing
IL1β release and delayed cell lysis, via caspase-3, and independent of GSDMD. Necroptosis (right panel) is a programmed form of necrosis commonly triggered by
tumor necrosis factor receptor (TNFR) or toll-like receptors (TLRs) upon inflammatory or neurodegenerative stimuli. Activation of these receptors leads to
receptor-interacting serine/threonine-protein kinase 1 (RIPK1) disengagement from the receptor platform and the rapid recruitment of RIPK3 and Casp8 to form the
ripoptosome. At this point, activation of caspase-8 will lead to apoptosis. However, absence or inhibition of caspase-8 will lead to phosphorylation of both RIPK1
and RIPK3 and the recruitment and phosphorylation of mixed lineage kinase domain like pseudokinase (MLKL). MLKL phosphorylation triggers its oligomerization,
gaining pore-forming activity that leads to cell lysis. (B) Inflammasomes described in different CNS cell types described in this paper.
Interestingly in neurons, a new interaction of RIPK3 with
the protein apoptosis-inducing factor (AIF) has been reported.
Their interaction and translocation into the nucleus in a model
of 20-min global cerebral ischemia/reperfusion (I/R) has been
described in CA1 neurons, which was critical to ischemic DNA
degradation and programmed necrosis (Xu et al., 2016). The
fact that these CA1 neurons lack caspase-8 expression, facilitates
necroptosis in these cells.
In astrocytes, a study performed in mouse spinal cord
astrocytes treated with LPS or TNF-α with zVAD in vitro, and
subjected to spinal cord injury (SCI) in vivo, showed an increase
in the expression of RIPK3 and MLKL proteins (Fan et al., 2016).
Treatment with the chemical inhibitor of RIPK1 (Necrostatin-1)
or RIPK3 genetic ablation (Fan et al., 2016) rescued the cells.
In the case of neurons, in a model of subarachnoid
hemorrhage it has been reported that neuronal death occurs
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via RIPK3 and MKLK (Chen et al., 2018; Yuan et al.,
2019). Moreover, inhibition of RIPK1 [using RIPK1-inhibitory
compound (RIC)] in retinal degenerative diseases induced by
glaucomatous insult has been proved to exert a neuroprotective
effect (Jang et al., 2019).
Intriguingly, while necroptosis of neurons, ODCs and
astrocytes is associated normally with demyelination and
neurodegeneration, a new report in microglia cells (Lloyd et al.,
2019) proposes that the remyelination process in white matter
is driven by proinflammatory microglia necroptosis and the
subsequent repopulation of positively regulated by type-1 IFN
signaling microglia.
Caspases and Synapses
In the mature CNS, caspases are not only involved in mediating
cell death but also regulatory events that are important
for neuronal functions, such as, axon pruning and synapse
elimination (D’Amelio et al., 2010; Hyman and Yuan, 2012;
Hollville and Deshmukh, 2018).
During axonal pruning, the absence of neurotrophic
factors provokes caspase-3/6 activation via JNK that facilitates
mitochondrial depolarization (Hollville and Deshmukh, 2018).
The role of caspases in axon pruning has also been studied
in the context of axon degeneration induced by neurotrophic
factor deprivation in sympathetic neurons. Caspase-3, caspase-6
or caspase-9 are required for the axon selective degeneration
or pruning (Simon et al., 2012) but not Apaf-1 (Cusack et al.,
2013), which is required for triggering cell death upon axonal
Neuronal Growth Factor (NGF) deprivation. Caspase-3 was
also found to control spine density and dendrite morphology in
specific areas within the cell generating supernumerary spines
in caspase-3 knockout mice (Ertürk et al., 2014). Caspase-
2 participates in the control of dendrite spine density via
activation of the RhoA/ROCK-II signaling pathway (Pozueta
et al., 2013). Caspase-2 deficiency in J20 APP transgenic mice
did not thwart cognitive function despite having similar Aβ
load and neuroinflammatory response to wild type animals
(Pozueta et al., 2013).
Caspases are also involved in axonal guidance and
synaptogenesis like for instance caspase-9-mediated cleavage of
Semaphorin 7 mediates the proper projection of axons in sensory
neurons (Ohsawa et al., 2010). In the spinal cord of neonatal
mice, caspase-3 regulates the number of axonal branches via
Bax/Bak in the axons of corticospinal neurons. Early postnatal
inactivation of Bax/Bak in motor cortex results in increased
axonal branches in the spine of these animals when they reach
adulthood. As a consequence, connectivity’s fine-tuning is
lost and animals fail to acquire fine voluntary movements
(Gu et al., 2017).
Normal brain functions depend on proper synaptic activity.
Long-term potentiation (LTP) and long-term depression (LTD)
are long-lasting modifications of synapses in the hippocampus
region. Activation of caspase-3 during LTD occurs without
cell death (Li et al., 2010; Simon et al., 2012) and facilitates
the internationalization of AMPA receptor in the postsynaptic
membrane. Furthermore, caspase-3 promotes modifications in
AMPA-type receptor that lead to alterations of glutamatergic
synaptic transmission and plasticity in Tg2576-APPSwe mice.
Notably, pharmacological inhibition of caspase-3 activity
in these mice rescued the observed AD-like phenotypes
(D’Amelio et al., 2011).
Caspases and Neurotoxic Protein
Aggregates
Caspases play a significant role in the pathogenesis of different
neurodegenerative diseases including AD, PD and Huntington’s
disease (HD), since they are able to modify the properties
of different neurotoxic proteins aggregates (amyloid precursor
protein (APP), Tau, α-synuclein (α-Syn) and huntingtin (htt)
through cleavage.
Under apoptotic conditions, caspases cleave APP, either
directly or following γ-secretase generation of the AICD
fragment, to generate the C31 and Jcasp peptides [for more
information see review (Nhan et al., 2015)]. While AICD and C31
are associated with cell death in vitro (Lu et al., 2000; Bertrand
et al., 2001; Park et al., 2009), the impact of this in vivo may
be minimal, since mice bearing mutant caspase-resistant APP
displayed no rescue in learning or memory in a mouse model of
AZ (Harris et al., 2010).
Tau is another substrate processed by caspases early in
the progression of AD (Rissman et al., 2004). Cleaved Tau
promotes nucleation-dependent filament formation which is
phosphorylated by glycogen synthase kinase-3b in a process
mediated by caspase-3 (Chu et al., 2017). Recently, it has been
shown that caspase-2 specific cleavage in Tau provokes an
inadequate sorting of Tau toward the dendritic spines, promoting
cognitive impairment and synaptic dysfunction (Zhao et al.,
2016). Interestingly, cleavage of APP promotes phosphorylation
of Tau in different residues, in a process where C31 binds to
the asparagine, proline, threonine, tyrosine (NPTY) motif of the
catalytic subunit of the phosphatase PP2A, repressing its activity
(Park et al., 2012).
α-Syn is an abundantly expressed neuronal protein
localized in the presynaptic terminals of neurons. α-Syn is
key to understanding the etiology of a group of overlapping
neurodegenerative disorders called α-synucleinopathies,
including PD. α-Syn is processed through caspase-1 forming a
truncated protein whose effect is to accelerate the formation of
aggregates as compared to the full-length form of α-Syn (Wang
et al., 2016). Interestingly, truncated α-Syn itself stimulates
caspase-1 activation which promotes more cleavage of α-Syn, in
a positive feedback loop (Ma et al., 2018).
Finally, caspase cleavage of htt induces it’s accumulation in the
nuclei of neurons of HD patients (Graham et al., 2010). Caspase-
6 cleaves htt, and caspase-6 activation has been observed before
the onset of motor abnormalities both in mouse and human
HD brains (Graham et al., 2010). Strikingly, in vivo experiments
using YAC mice expressing caspase-6-resistant cleavage of htt,
showed no striatal neurodegeneration. Recently a new caspase
cleavage site of htt has been described, in this case depending
on caspase-1 activity that promotes aggregation of mutant htt
(Martin et al., 2019).
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While the evidence gathered in PD and HD studies suggests
that caspase-dependent processing of α-Syn and htt may play a
role in the pathogenesis of the diseases, conflicting results for APP
in vitro and in vivo have been observed in AD models, requiring
further investigation.
Also, the experiments to study cleavage of APP by caspases
have been performed under apoptotic conditions, which makes
difficult to conclude if the caspase cleavage of APP plays any
pathological role or is just “collateral damage” that occurs during
apoptosis. Further experiments under non-cell death conditions
should be performed to resolve this issue.
Caspases and Autophagy and
Mitochondria Biogenesis
Autophagy is a catabolic process that delivers cytoplasmic
constituents into lysosome for degradation and eventual
recycling. Under physiological conditions, autophagy promotes
cell survival by elimination of damaged organelles and proteins
aggregates (Zare-Shahabadi et al., 2015). However, autophagy
has also been linked to cell death, either promoting it (Das
et al., 2012) or at least being associated with it (Kroemer
and Levine, 2008). Evidence suggests that autophagy may
be controlled by caspases during apoptosis (Tsapras and
Nezis, 2017). However, evidence of the interaction between
autophagy-related proteins and caspases in the CNS are still
scarce. In primary cultures of cortical neurons treated with
rotenone, lack of caspase-2 prolonged cell survival by enhancing
autophagy. However, the cells die eventually via necrosis
(Tiwari et al., 2011).
A recent study showed that caspase-3-induced Beclin-1
cleavage and subcellular redistribution of the Beclin-1 N-terminal
into the nucleus has been shown in neuron-glia co-cultures with
Aβ1−42 and APPSwe/PS1dE9 mice. The authors hypothesized
that cleavage of Beclin-1 by caspase-3 could affect autophagy
and lead to defective protein clearance and neuronal death
(Wang et al., 2017).
Despite all these roles that we have discussed in this mini-
review, new and exciting roles are still emerging for caspases
in the CNS. For instance, in a recent study performed by Kim
et al. (2018) in dopaminergic neurons, the authors described
how procaspase-3 acts as a regulator for mitochondria biogenesis
without affecting autophagy. They showed that TFAM, Nrf-1, and
PGC-1a (transcriptional activators of mitochondrial biogenesis)
are regulated by procaspase-3. Furthermore, in the same study,
the authors show that lack of procaspase-3 in dopaminergic
neurons dramatically reduced electron transport chain complex
I, II, and IV activity. Interestingly, treatment with caspase-
3 inhibitor failed to mimic the observed effects thus raising
the view that caspase-3-dependent mitochondrial biogenesis is
independent of its catalytic activity.
DISCUSSION
Within the last decade, there has been an exponential growth in
the number of studies of non-apoptotic functions of caspases.
Some of these non-apoptotic roles have been extensively
studied in specific cell types, such as the inflammasome in
immune cells (Martinon et al., 2002). In the CNS, while
many of these non-apoptotic functions have been studied
in microglia cells, few reports have been published for
neurons, astrocytes and ODCs in comparison. Here we
attempt to shed light onto some “old and new” non-apoptotic
functions for caspases in these cell types, which have been
gathering momentum in recent years and their relevance under
pathological conditions.
Why does the activation of executioner caspases not translate
always into an apoptotic process? A possible explanation
could be sequestration of effector caspases into different
subcellular compartments (Li et al., 2010; Kavanagh et al., 2014;
Amcheslavsky et al., 2018) and/or cleavage of non-cell death
related substrates (Acarin et al., 2007).
Different manners in which caspases affect cellular signaling
continue to emerge. Besides the diverse mechanisms employed
to activate different caspases already commented in this
mini-review, it has been shown that the reduction of the
basal activity of caspase-3 promotes a change toward a
tumor supportive phenotype in microglia cells in contact
with glioma cells (Shen et al., 2016). Also, and in agreement
with this, in embryonic stem cells (ESCs), basal caspase-3
activity regulates cell differentiation of these cells through
Nanog processing (Baena-Lopez et al., 2018). We have also
discussed previously in this mini-review how the zymogen
(procaspase-3) mediates the mitochondrial biogenesis
independently of its enzymatic activity (Kim et al., 2018). It
is possible that these functions of caspase-3 can be extended
to other caspases, opening new possibilities in the field
of caspase biology, for new mechanistic roles of caspases
with relevance not only limited to the CNS but applicable
to all cell types.
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